Are you Dr. Leibowitz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2600 Redondo Ave
Suite 500
Long Beach, CA 90806Phone+1 562-304-1742Fax+1 562-981-0374
Summary
- Dr. Mark Leibowitz, MD is an internist in Long Beach, California. He is currently licensed to practice medicine in California, Georgia, and Texas.
Education & Training
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1982 - 1985
Albert Einstein College of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1984 - 2026
TX State Medical License 1984 - 2025
GA State Medical License 1996 - 2013
Clinical Trials
- Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment Start of enrollment: 2010 Feb 01
- A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers. Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 7 citationsDihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing.Peter R. Bieck, Mark Leibowitz, D. Richard Lachno, Edouard Ledent, Robert Padich
Journal of Clinical Psychopharmacology. 2016-12-01 - 48 citationsSingle‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moder...Carol Addy, Chris Assaid, David Hreniuk, Mark Stroh, Yang Xu
Journal of Clinical Pharmacology. 2009-07-01 - 17 citationsSimilarity of insulin detemir pharmacokinetics, safety, and tolerability profiles in healthy caucasian and Japanese american subjects.Stan S. Jhee, William Lyness, Patrick B. Rojas, Mark Leibowitz, Victoria Zarotsky
Journal of Clinical Pharmacology. 2004-03-01
